What are the risks of investing in AURA?
A
What are the risks of investing in AURA?
🦉
Aura Biosciences, Inc. (AURA)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOElisabet de los Pinos
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the...
Key Executives
| Name | Title |
|---|---|
| Amy Elazzouzi | Interim Principal Accounting Officer, Senior Vice President of Finance & Treasurer |
| Anthony Daniels | Vice President & Therapeutic Area of Head Ocular Oncology |
| Anthony S. Gibney | Chief Financial & Business Officer |
| Conor Kilroy | Chief Legal Officer & Secretary |
| Elisabet de los Pinos | Founder, Chief Executive Officer, President & Director |
| Jill Hopkins | Chief Medical Officer & President of Research and Development |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A